Holocene Advisors’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-188,989
| Closed | -$7.38M | – | 824 |
|
|
2025
Q1 | $7.38M | Sell |
188,989
-1,396,178
| -88% | -$54.5M | 0.02% | 308 |
|
|
2024
Q4 | $85.8M | Hold |
1,585,167
| – | – | 0.27% | 105 |
|
|
2024
Q3 | $79.9M | Sell |
1,585,167
-41,174
| -3% | -$2.08M | 0.32% | 102 |
|
|
2024
Q2 | $71.5M | Buy |
1,626,341
+171,472
| +12% | +$7.54M | 0.3% | 101 |
|
|
2024
Q1 | $73.1M | Buy |
1,454,869
+493,539
| +51% | +$24.8M | 0.27% | 118 |
|
|
2023
Q4 | $58.1M | Buy |
961,330
+855,508
| +808% | +$51.7M | 0.23% | 136 |
|
|
2023
Q3 | $6.03M | Buy |
+105,822
| New | +$6.03M | 0.03% | 354 |
|